APA

Brabants E., Heyns K., De Smet S., Devreker P., Ingels J., De Cabooter N., Debacker V., Dullaers M., VAN Meerbeeck J. P., Vandekerckhove B. & Vermaelen K. Y. (20191008). An accelerated, clinical-grade protocol to generate high yields of type 1-polarizing messenger RNA-loaded dendritic cells for cancer vaccination. : Cytotherapy.

Chicago

Brabants E, Heyns K, De Smet S, Devreker P, Ingels J, De Cabooter N, Debacker V, Dullaers M, VAN Meerbeeck J P, Vandekerckhove B and Vermaelen K Y. 20191008. An accelerated, clinical-grade protocol to generate high yields of type 1-polarizing messenger RNA-loaded dendritic cells for cancer vaccination. : Cytotherapy.

Harvard

Brabants E., Heyns K., De Smet S., Devreker P., Ingels J., De Cabooter N., Debacker V., Dullaers M., VAN Meerbeeck J. P., Vandekerckhove B. and Vermaelen K. Y. (20191008). An accelerated, clinical-grade protocol to generate high yields of type 1-polarizing messenger RNA-loaded dendritic cells for cancer vaccination. : Cytotherapy.

MLA

Brabants E, Heyns K, De Smet S, Devreker P, Ingels J, De Cabooter N, Debacker V, Dullaers M, VAN Meerbeeck J P, Vandekerckhove B and Vermaelen K Y. An accelerated, clinical-grade protocol to generate high yields of type 1-polarizing messenger RNA-loaded dendritic cells for cancer vaccination. : Cytotherapy. 20191008.